These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33037452)

  • 1. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
    Fotio Y; Ciccocioppo R; Piomelli D
    Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
    Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
    Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
    Migliore M; Pontis S; Fuentes de Arriba AL; Realini N; Torrente E; Armirotti A; Romeo E; Di Martino S; Russo D; Pizzirani D; Summa M; Lanfranco M; Ottonello G; Busquet P; Jung KM; Garcia-Guzman M; Heim R; Scarpelli R; Piomelli D
    Angew Chem Int Ed Engl; 2016 Sep; 55(37):11193-11197. PubMed ID: 27404798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive Profile of ARN19702, (2-Ethylsulfonylphenyl)-[(2S)-4-(6-fluoro-1,3-benzothiazol-2-yl)-2-methylpiperazin-1-yl]methanone, a Novel Orally Active
    Fotio Y; Sasso O; Ciccocioppo R; Piomelli D
    J Pharmacol Exp Ther; 2021 Aug; 378(2):70-76. PubMed ID: 33986036
    [No Abstract]   [Full Text] [Related]  

  • 5. An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis.
    Bonezzi FT; Sasso O; Pontis S; Realini N; Romeo E; Ponzano S; Nuzzi A; Fiasella A; Bertozzi F; Piomelli D
    J Pharmacol Exp Ther; 2016 Mar; 356(3):656-63. PubMed ID: 26769918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the discovery of N-acylethanolamine acid amidase inhibitors.
    Bandiera T; Ponzano S; Piomelli D
    Pharmacol Res; 2014 Aug; 86():11-7. PubMed ID: 24798679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.
    Ponzano S; Bertozzi F; Mengatto L; Dionisi M; Armirotti A; Romeo E; Berteotti A; Fiorelli C; Tarozzo G; Reggiani A; Duranti A; Tarzia G; Mor M; Cavalli A; Piomelli D; Bandiera T
    J Med Chem; 2013 Sep; 56(17):6917-34. PubMed ID: 23991897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
    Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
    Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
    Melis M; Pillolla G; Luchicchi A; Muntoni AL; Yasar S; Goldberg SR; Pistis M
    J Neurosci; 2008 Dec; 28(51):13985-94. PubMed ID: 19091987
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M
    J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward.
    Sagheddu C; Scherma M; Congiu M; Fadda P; Carta G; Banni S; Wood JT; Makriyannis A; Malamas MS; Pistis M
    Neuropharmacology; 2019 Jan; 144():327-336. PubMed ID: 30439418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity-Based Probe for N-Acylethanolamine Acid Amidase.
    Romeo E; Ponzano S; Armirotti A; Summa M; Bertozzi F; Garau G; Bandiera T; Piomelli D
    ACS Chem Biol; 2015 Sep; 10(9):2057-2064. PubMed ID: 26102511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis.
    Sasso O; Summa M; Armirotti A; Pontis S; De Mei C; Piomelli D
    J Invest Dermatol; 2018 Mar; 138(3):562-569. PubMed ID: 29054595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis.
    Zhou P; Xiang L; Yang Y; Wu Y; Hu T; Liu X; Lin F; Xiu Y; Wu K; Lu C; Ren J; Qiu Y; Li Y
    Pharmacol Res; 2019 Jul; 145():104264. PubMed ID: 31063807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A; Cannella N; Braconi S; Duranti A; Tontini A; Bilbao A; Defonseca FR; Piomelli D; Ciccocioppo R
    Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats.
    Murillo-Rodríguez E; Palomero-Rivero M; Millán-Aldaco D; Arias-Carrión O; Drucker-Colín R
    PLoS One; 2011; 6(7):e20766. PubMed ID: 21779318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acylethanolamine acid amidase (NAAA), a new path to unleash PPAR-mediated analgesia.
    Taylor BK
    Pain; 2013 Mar; 154(3):326-327. PubMed ID: 23333052
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
    Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D
    Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.
    Fiasella A; Nuzzi A; Summa M; Armirotti A; Tarozzo G; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
    ChemMedChem; 2014 Jul; 9(7):1602-14. PubMed ID: 24828120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
    Alhouayek M; Bottemanne P; Subramanian KV; Lambert DM; Makriyannis A; Cani PD; Muccioli GG
    FASEB J; 2015 Feb; 29(2):650-61. PubMed ID: 25384424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.